Genelux Corporation (GNLX)
NASDAQ: GNLX · Real-Time Price · USD
2.550
+0.090 (3.66%)
At close: Nov 22, 2024, 4:00 PM
2.570
+0.020 (0.78%)
After-hours: Nov 22, 2024, 5:01 PM EST
Genelux Market Cap
Genelux has a market cap or net worth of $86.96 million as of November 22, 2024. Its market cap has decreased by -76.22% in one year.
Market Cap
86.96M
Enterprise Value
54.94M
1-Year Change
-76.22%
Ranking
Category
Stock Price
$2.55
Market Cap Chart
Since the IPO on January 26, 2023, Genelux's market cap has decreased from $141.69M to $86.96M, a decrease of -38.63%. That is a compound annual growth rate of -23.57%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 19, 2024 | 84.57M | -77.41% |
| Dec 29, 2023 | 374.31M | 164.17% |
| Jan 26, 2023 | 141.69M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Generation Bio Co. | 88.17M |
| Genenta Science | 87.79M |
| HilleVax | 87.79M |
| LENSAR | 86.53M |
| WORK Medical Technology Group LTD | 84.05M |
| Invivyd | 83.71M |
| FibroBiologics | 83.53M |
| Ikena Oncology | 83.49M |